These results, along with a former report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two guidance the concept of concentrating on ACKR3 as a novel strategy to modulate the opioid process, which could open up new therapeutic avenues for opioid-connected disorders. Disclaimer: The above mentioned https://actono689uuj7.wikinewspaper.com/user